| 000 | 01549 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513222457.0 | ||
| 264 | 0 | _c20010108 | |
| 008 | 200101s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/s0014-2999(00)00543-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrinton, R D | |
| 245 | 0 | 0 |
_aSpatial, cellular and temporal basis of vasopressin potentiation of norepinephrine-induced cAMP formation. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cSep 2000 |
||
| 300 |
_a73-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Agonists _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAutoradiography |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCyclic AMP _xbiosynthesis |
| 650 | 0 | 4 |
_aDentate Gyrus _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeuroglia _xdrug effects |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta-1 _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Vasopressin _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVasopressins _xpharmacology |
| 700 | 1 | _aThompson, R H | |
| 700 | 1 | _aBrownson, E A | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 405 _gno. 1-3 _gp. 73-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(00)00543-4 _zAvailable from publisher's website |
| 999 |
_c10978401 _d10978401 |
||